Peng S[au] - Search Results

Year	Number of Results
1954	1
1959	1
1965	1
1966	1
1972	2
1973	1
1974	1
1975	1
1976	4
1977	1
1978	3
1979	5
1980	1
1981	4
1982	1
1983	5
1984	5
1985	7
1986	4
1987	10
1988	12
1989	12
1990	19
1991	18
1992	19
1993	19
1994	21
1995	23
1996	37
1997	30
1998	37
1999	38
2000	36
2001	47
2002	77
2003	103
2004	123
2005	118
2006	126
2007	140
2008	153
2009	162
2010	174
2011	201
2012	217
2013	299
2014	333
2015	344
2016	376
2017	393
2018	468
2019	546
2020	608
2021	690
2022	880
2023	858
2024	892
2025	7

1

Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders.

Peng S, Liu J, Liang C, Yang L, Wang G. Peng S, et al. Neurobiol Dis. 2023 Apr;179:106035. doi: 10.1016/j.nbd.2023.106035. Epub 2023 Feb 15. Neurobiol Dis. 2023. PMID: 36796590 Free article. Review.

2

METTL3-m⁶A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma.

Wang L, Yang Q, Zhou Q, Fang F, Lei K, Liu Z, Zheng G, Zhu L, Huo J, Li X, Peng S, Kuang M, Lin S, Huang M, Xu L. Wang L, et al. Among authors: peng s. Cancer Lett. 2023 Apr 10;559:216122. doi: 10.1016/j.canlet.2023.216122. Epub 2023 Mar 9. Cancer Lett. 2023. PMID: 36898427

3

The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis.

Peng S, Shen L, Yu X, Zhang L, Xu K, Xia Y, Zha L, Wu J, Luo H. Peng S, et al. Front Immunol. 2023 Jun 5;14:1200111. doi: 10.3389/fimmu.2023.1200111. eCollection 2023. Front Immunol. 2023. PMID: 37359553 Free PMC article. Review.

4

Neoantigen-targeted CD8⁺ T cell responses with PD-1 blockade therapy.

Puig-Saus C, Sennino B, Peng S, Wang CL, Pan Z, Yuen B, Purandare B, An D, Quach BB, Nguyen D, Xia H, Jilani S, Shao K, McHugh C, Greer J, Peabody P, Nayak S, Hoover J, Said S, Jacoby K, Dalmas O, Foy SP, Conroy A, Yi MC, Shieh C, Lu W, Heeringa K, Ma Y, Chizari S, Pilling MJ, Ting M, Tunuguntla R, Sandoval S, Moot R, Hunter T, Zhao S, Saco JD, Perez-Garcilazo I, Medina E, Vega-Crespo A, Baselga-Carretero I, Abril-Rodriguez G, Cherry G, Wong DJ, Hundal J, Chmielowski B, Speiser DE, Bethune MT, Bao XR, Gros A, Griffith OL, Griffith M, Heath JR, Franzusoff A, Mandl SJ, Ribas A. Puig-Saus C, et al. Among authors: peng s. Nature. 2023 Mar;615(7953):697-704. doi: 10.1038/s41586-023-05787-1. Epub 2023 Mar 8. Nature. 2023. PMID: 36890230 Free PMC article.

5

BDNF as a biomarker in diagnosis and evaluation of treatment for schizophrenia and depression.

Peng S, Li W, Lv L, Zhang Z, Zhan X. Peng S, et al. Discov Med. 2018 Oct;26(143):127-136. Discov Med. 2018. PMID: 30586536 Free article. Review.

6

Mechanical confinement promotes heat resistance of hepatocellular carcinoma via SP1/IL4I1/AHR axis.

Zhang GP, Xie ZL, Jiang J, Zhao YT, Lei K, Lin ZL, Chen SL, Su TH, Tan L, Peng S, Wang J, Liu C, Kuang M. Zhang GP, et al. Among authors: peng s. Cell Rep Med. 2023 Aug 15;4(8):101128. doi: 10.1016/j.xcrm.2023.101128. Epub 2023 Jul 20. Cell Rep Med. 2023. PMID: 37478857 Free PMC article.

7

Advanced Cardiac Patches for the Treatment of Myocardial Infarction.

Liu T, Hao Y, Zhang Z, Zhou H, Peng S, Zhang D, Li K, Chen Y, Chen M. Liu T, et al. Among authors: peng s. Circulation. 2024 Jun 18;149(25):2002-2020. doi: 10.1161/CIRCULATIONAHA.123.067097. Epub 2024 Jun 17. Circulation. 2024. PMID: 38885303 Free PMC article. Review.

8

Fasting-mimicking diet synergizes with ferroptosis against quiescent, chemotherapy-resistant cells.

Liu X, Peng S, Tang G, Xu G, Xie Y, Shen D, Zhu M, Huang Y, Wang X, Yu H, Huang M, Luo Y. Liu X, et al. Among authors: peng s. EBioMedicine. 2023 Apr;90:104496. doi: 10.1016/j.ebiom.2023.104496. Epub 2023 Feb 28. EBioMedicine. 2023. PMID: 36863257 Free PMC article.

9

Alterations in the gut virome are associated with type 2 diabetes and diabetic nephropathy.

Fan G, Cao F, Kuang T, Yi H, Zhao C, Wang L, Peng J, Zhuang Z, Xu T, Luo Y, Xie Y, Li H, Zhang K, Zeng Y, Zhang X, Peng S, Qiu X, Zhou D, Liang H, Yang B, Kang J, Liu Y, Zhang Y. Fan G, et al. Among authors: peng s. Gut Microbes. 2023 Jan-Dec;15(1):2226925. doi: 10.1080/19490976.2023.2226925. Gut Microbes. 2023. PMID: 37349979 Free PMC article.

10

Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low.

Hu XE, Yang P, Chen S, Wei G, Yuan L, Yang Z, Gong L, He L, Yang L, Peng S, Dong Y, He X, Bao G. Hu XE, et al. Among authors: peng s. Breast Cancer Res. 2023 Mar 30;25(1):34. doi: 10.1186/s13058-023-01639-y. Breast Cancer Res. 2023. PMID: 36998014 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,851 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,851 results

Results by year